Sign Up for a Free Account
  • Updated 04.07.2020
  • Released 02.25.1994
  • Expires For CME 04.07.2023

Neonatal herpes encephalitis


This article includes discussion of neonatal herpes encephalitis, disseminated herpes infection with encephalitis, localized CNS neonatal herpes infections, and congenital herpes encephalitis. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations.


Herpes simplex virus encephalitis is a catastrophic disease of newborns. Without specific therapy, 40% to 50% of neonates with this infection will die, and survivors have a high rate of neurologic sequelae. Herpes simplex virus cultures and polymerase chain reaction can reliably demonstrate herpes simplex virus infection in many neonates with herpes simplex encephalitis. However, antiviral treatment should be started immediately in all cases of suspected neonatal herpes simplex virus encephalitis because delay of treatment can substantially worsen outcome. In this update, the authors present a vignette of herpes simplex encephalitis with typical symptoms, radiographic findings, laboratory results, and outcome. In addition, the authors discuss effective measures to prevent, diagnose, and treat this devastating infection.

Key points

• In most cases of neonatal herpes encephalitis, the infection is acquired during the birthing process.

• The application of polymerase chain reaction to CSF samples has revolutionized the diagnosis of central nervous system disease in neonates, as this method allows rapid and reliable detection of the viral infection.

• Prompt institution of antiviral therapy is critical to minimize mortality and morbidity.

• As CNS disease has significant morbidity, strategies to prevent vertical transmission are of fundamental importance.

• Oral acyclovir suppression following acute treatment of neonatal herpes encephalitis improves neurodevelopmental outcome at 1 year.

Historical note and terminology

"Herpes," from the Greek meaning "creeping or crawling," has been used historically as a descriptor for a variety of febrile illnesses associated with vesicular exanthems or enanthems. Many of these infectious illnesses, such as herpangina, are recognized today, however, as being caused by infective agents other than the herpes viruses. More than 50 viruses are classified in the family of herpesviruses, but the most important with regard to human illness are herpes simplex viruses 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpes viruses 6, 7, and 8 (HHV-6, HHV-7, and HHV-8). Although all of these viruses can cause intrauterine and neonatal CNS infections, herpes simplex virus is the most common cause of acute, life-threatening neonatal encephalitis.

The clinical manifestations of herpes simplex virus infections in older children and adults have been known for centuries. However, it was not until the 1930s that clinical reports began to appear that distinguished neonatal herpes infection as a distinct clinical entity (19; 51).

In the early and mid-1960s, viral culture and immunologic techniques were developed that made it possible to distinguish herpes simplex virus-1 from herpes simplex virus-2 (36). Using these laboratory techniques, investigators have defined more clearly the epidemiology and pathogenesis of infections with these 2 types of herpes simplex virus (37; 38; 39). Herpes simplex virus-1 infects primarily the mouth, lips, eyes, and skin of the upper body and is the major cause of herpes encephalitis seen after the neonatal period. Herpes simplex virus-2 infects primarily the genital tract and skin of the lower body and causes most of cases of neonatal herpes simplex virus encephalitis. With further advances in virology and immunology during the 1970s and 1980s, knowledge regarding herpes simplex virus transmission, replication, latency, and reactivation expanded markedly. Based on the better understanding of the epidemiology, pathogenesis, and biology of herpes simplex virus infections that has been achieved during the past 15 to 20 years, major advances have occurred in prevention of neonatal herpes simplex virus infection and in the development of effective, safe, and specific anti-herpes simplex virus drugs.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660